These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 6498839

  • 21. Influence of radical prostatectomy on serum hormone levels.
    Miller LR, Partin AW, Chan DW, Bruzek DJ, Dobs AS, Epstein JI, Walsh PC.
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G.
    J Cell Biochem; 2007 Nov 01; 102(4):899-911. PubMed ID: 17786930
    [Abstract] [Full Text] [Related]

  • 24. The prostate gland and prostate carcinogenesis.
    Wong YC, Wang YZ, Tam NN.
    Ital J Anat Embryol; 1998 Nov 01; 103(4 Suppl 1):237-52. PubMed ID: 11315954
    [Abstract] [Full Text] [Related]

  • 25. Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio.
    Yatkin E, Bernoulli J, Talvitie EM, Santti R.
    Int J Androl; 2009 Aug 01; 32(4):399-410. PubMed ID: 19515173
    [Abstract] [Full Text] [Related]

  • 26. Tissue evidence of the testosterone role on the abnormal growth and aging effects reversion in the gerbil (Meriones unguiculatus) prostate.
    Scarano WR, Vilamaior PS, Taboga SR.
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Nov 01; 288(11):1190-200. PubMed ID: 17031809
    [Abstract] [Full Text] [Related]

  • 27. No effect of a high-fat diet on promotion of sex hormone-induced prostate and mammary carcinogenesis in the Noble rat model.
    Leung G, Benzie IF, Cheung A, Tsao SW, Wong YC.
    Br J Nutr; 2002 Oct 01; 88(4):399-409. PubMed ID: 12323089
    [Abstract] [Full Text] [Related]

  • 28. Spontaneous mammary tumors in aging Noble rats.
    Cheung SY, Choi HL, James AE, Chen ZY, Huang Y, Chan FL.
    Int J Oncol; 2003 Feb 01; 22(2):449-57. PubMed ID: 12527947
    [Abstract] [Full Text] [Related]

  • 29. Serum inhibin--not a cause of low testosterone levels in hypogonadal prostate cancer?
    Lackner JE, Maerk I, Koller A, Bieglmayer C, Marberger M, Kratzik C, Schatzl G.
    Urology; 2008 Nov 01; 72(5):1121-4. PubMed ID: 18407338
    [Abstract] [Full Text] [Related]

  • 30. Is low serum free testosterone a marker for high grade prostate cancer?
    Hoffman MA, DeWolf WC, Morgentaler A.
    J Urol; 2000 Mar 01; 163(3):824-7. PubMed ID: 10687985
    [Abstract] [Full Text] [Related]

  • 31. Aging-associated changes in gene expression in the ACI rat prostate: Implications for carcinogenesis.
    Reyes I, Reyes N, Iatropoulos M, Mittelman A, Geliebter J.
    Prostate; 2005 May 01; 63(2):169-86. PubMed ID: 15486989
    [Abstract] [Full Text] [Related]

  • 32. Gross and microscopic pathology of induced prostatic complex tumors arising in Lobund-Wistar rats.
    Cohen MB, Heidger PM, Lubaroff DM.
    Cancer Res; 1994 Feb 01; 54(3):626-8. PubMed ID: 7508335
    [Abstract] [Full Text] [Related]

  • 33. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy.
    Morote J, Orsola A, Planas J, Trilla E, Raventós CX, Cecchini L, Catalán R.
    J Urol; 2007 Oct 01; 178(4 Pt 1):1290-5. PubMed ID: 17698136
    [Abstract] [Full Text] [Related]

  • 34. Altered prostatic epithelial proliferation and apoptosis, prostatic development, and serum testosterone in mice lacking cyclin-dependent kinase inhibitors.
    Mukai M, Dong Q, Hardy MP, Kiyokawa H, Peterson RE, Cooke PS.
    Biol Reprod; 2005 Nov 01; 73(5):951-8. PubMed ID: 16014817
    [Abstract] [Full Text] [Related]

  • 35. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep 01; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 36. Rapid suppression of plasma testosterone levels and tumor growth in the dunning rat model treated with degarelix, a new gonadotropin-releasing hormone antagonist.
    Princivalle M, Broqua P, White R, Meyer J, Mayer G, Elliott L, Bjarnason K, Haigh R, Yea C.
    J Pharmacol Exp Ther; 2007 Mar 01; 320(3):1113-8. PubMed ID: 17179469
    [Abstract] [Full Text] [Related]

  • 37. Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model.
    Cho YM, Takahashi S, Asamoto M, Suzuki S, Tang M, Shirai T.
    Prostate Cancer Prostatic Dis; 2007 Mar 01; 10(4):378-83. PubMed ID: 17457304
    [Abstract] [Full Text] [Related]

  • 38. Protective effect of a polyherbal preparation, Brahma rasayana against tumor growth and lung metastasis in rat prostate model system.
    Gaddipati JP, Rajeshkumar NV, Thangapazham RL, Sharma A, Warren J, Mog SR, Singh AK, Maheshwari RK.
    J Exp Ther Oncol; 2004 Oct 01; 4(3):203-12. PubMed ID: 15724840
    [Abstract] [Full Text] [Related]

  • 39. Steroid hormones and carcinogenesis of the prostate: the role of estrogens.
    Ricke WA, Wang Y, Cunha GR.
    Differentiation; 2007 Nov 01; 75(9):871-82. PubMed ID: 17924963
    [Abstract] [Full Text] [Related]

  • 40. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA, Giovannucci E.
    J Steroid Biochem Mol Biol; 2004 Nov 01; 92(4):237-53. PubMed ID: 15663987
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.